
|Videos|June 23, 2015
Importance of Provider Status in Value-Based Care
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx explains the important of provider status in value-based care.
Advertisement
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx explains the important of provider status in value-based care.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Ziftomenib Receives FDA Approval for Acute Myeloid Leukemia With NPM1 Mutations
3
The Dual Burden of CAR T-Cell Therapy: Financial and Time Toxicity in the Era of Precision Oncology
4
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
5






















































































































































































































